141 related articles for article (PubMed ID: 9163612)
21. Hypersensitivity of circulating progenitor cells to megakaryocyte growth and development factor (PEG-rHu MGDF) in essential thrombocythemia.
Axelrad AA; Eskinazi D; Correa PN; Amato D
Blood; 2000 Nov; 96(10):3310-21. PubMed ID: 11071622
[TBL] [Abstract][Full Text] [Related]
22. Primary polycythaemia, essential thrombocythaemia and myelofibrosis--three facets of a single disease process?
Adams JA; Barrett AJ; Beard J; McCarthy DM
Acta Haematol; 1988; 79(1):33-7. PubMed ID: 3124458
[TBL] [Abstract][Full Text] [Related]
23. Essential thrombocythaemia with aggressive megakaryocytosis after myelofibrotic transformation.
Sasaki K; Nannya Y; Nakamura Y; Ichikawa M; Ogawa S; Mitani K
Hematology; 2021 Dec; 26(1):594-600. PubMed ID: 34402416
[TBL] [Abstract][Full Text] [Related]
24. Serial serum thrombopoietin levels in a pregnant woman with essential thrombocythaemia.
Kanda Y; Chiba S; Tanaka Y; Miwa A; Togawa A; Kato T; Miyazaki H; Nishino R; Yazaki Y; Hirai H
Br J Haematol; 1999 Apr; 105(1):271-3. PubMed ID: 10233392
[TBL] [Abstract][Full Text] [Related]
25. Milestones in understanding platelet production: a historical overview.
Kuter DJ
Br J Haematol; 2014 Apr; 165(2):248-58. PubMed ID: 24528208
[TBL] [Abstract][Full Text] [Related]
26. Transforming growth factor β- and interleukin 13-producing mast cells are associated with fibrosis in bone marrow.
Nakayama S; Yokote T; Hiraoka N; Akioka T; Nishiwaki U; Miyoshi T; Iwaki K; Fumimoto A; Masuda Y; Hatooka J; Fujimoto M; Nishimura Y; Tsuji M
Hum Pathol; 2017 Apr; 62():180-186. PubMed ID: 28159675
[TBL] [Abstract][Full Text] [Related]
27. Thrombopoietin: biology and clinical potentials.
Miyazaki H; Kato T
Int J Hematol; 1999 Dec; 70(4):216-25. PubMed ID: 10643146
[TBL] [Abstract][Full Text] [Related]
28. A pathobiologic pathway linking thrombopoietin, GATA-1, and TGF-beta1 in the development of myelofibrosis.
Vannucchi AM; Bianchi L; Paoletti F; Pancrazzi A; Torre E; Nishikawa M; Zingariello M; Di Baldassarre A; Rana RA; Lorenzini R; Alfani E; Migliaccio G; Migliaccio AR
Blood; 2005 May; 105(9):3493-501. PubMed ID: 15665119
[TBL] [Abstract][Full Text] [Related]
29. Familial essential thrombocythemia with spontaneous megakaryocyte colony formation and acquired JAK2 mutations.
Higgs JR; Sadek I; Neumann PE; Ing VW; Renault NK; Berman JN; Greer WL
Leukemia; 2008 Aug; 22(8):1551-6. PubMed ID: 18496561
[TBL] [Abstract][Full Text] [Related]
30. Myelofibrosis and acute megakaryoblastic leukemia in a child: topographic relationship between fibroblasts and megakaryocytes with an alpha-granule defect.
Breton-Gorius J; Bizet M; Reyes F; Dupuy E; Mear C; Vannier JP; Tron P
Leuk Res; 1982; 6(1):97-110. PubMed ID: 6461801
[TBL] [Abstract][Full Text] [Related]
31. Rescue of a primary myelofibrosis model by retinoid-antagonist therapy.
Hong SH; Dvorak-Ewell M; Stevens HY; Barish GD; Castro GL; Nofsinger R; Frangos JA; Shoback D; Evans RM
Proc Natl Acad Sci U S A; 2013 Nov; 110(47):18820-5. PubMed ID: 24191050
[TBL] [Abstract][Full Text] [Related]
32. Spontaneous in vitro megakaryocyte colony formation in primary thrombocythemia: relation to platelet factor 4 plasma level and beta-thromboglobulin/platelet factor 4 ratio.
Abgrall JF; Berthou C; Cauvin JM; Autrand C; Renard I; Le Niger C; Guern G; Blouch MT; Sensebé L; Brière J
Acta Haematol; 1992; 87(3):118-21. PubMed ID: 1386487
[TBL] [Abstract][Full Text] [Related]
33. [Clinical use of thrombopoietin (c-Mpl Ligand)].
Borota R; Borota J; Belić A; Gebauer E; Stefanović N
Med Pregl; 1998; 51(11-12):501-8. PubMed ID: 10081270
[TBL] [Abstract][Full Text] [Related]
34. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group.
Michiels JJ; Juvonen E
Semin Thromb Hemost; 1997; 23(4):339-47. PubMed ID: 9263350
[TBL] [Abstract][Full Text] [Related]
35. Myelofibrosis with myeloid metaplasia following essential thrombocythaemia.
Liberato NL; Barosi G; Costa A; D'Elia P; Boccaccio P
Acta Haematol; 1989; 82(3):150-3. PubMed ID: 2510437
[TBL] [Abstract][Full Text] [Related]
36. Megakaryocytopoiesis in vitro of patients with essential thrombocythaemia: effect of plasma and serum on megakaryocytic colony formation.
Komatsu N; Suda T; Sakata Y; Eguchi M; Kaji K; Saito M; Miura Y
Br J Haematol; 1986 Oct; 64(2):241-52. PubMed ID: 3490877
[TBL] [Abstract][Full Text] [Related]
37. Thrombopoietin mobilizes CD34+ cell subsets into peripheral blood and expands multilineage progenitors in bone marrow of cancer patients with normal hematopoiesis.
Murray LJ; Luens KM; Estrada MF; Bruno E; Hoffman R; Cohen RL; Ashby MA; Vadhan-Raj S
Exp Hematol; 1998 Mar; 26(3):207-16. PubMed ID: 9502616
[TBL] [Abstract][Full Text] [Related]
38. Disparate effects of interleukin 11 and thrombopoietin on megakaryocytopoiesis in vitro.
Taguchi K; Saitoh M; Arai Y; Momose K; Ogawa Y; Yasuda S; Miyata K
Cytokine; 2001 Sep; 15(5):241-9. PubMed ID: 11594788
[TBL] [Abstract][Full Text] [Related]
39. [Dysmegakaryocytopoiesis and dysthrombopoiesis in myeloproliferative syndromes].
Brière J; Kiladjian JJ; Peynaud-Debayle E
C R Seances Soc Biol Fil; 1996; 190(5-6):533-9. PubMed ID: 9074718
[TBL] [Abstract][Full Text] [Related]
40. [Thrombopoietin is a multifunctional factor].
Hino M
Rinsho Byori; 1997 Oct; 45(10):921-6. PubMed ID: 9369068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
